ORION PHARMA: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
ORION PHARMA
Largest movements
- Receivables within one year -€294,950
down €294,950 (-34.8%), from €847,145 to €552,195
of which Trade receivables: -€227,158
- Cash +€232,595
up €232,595 (+119%), from €195,116 to €427,711
mainly Receivables within one year (+€294,950) and Net result for the year (+€137,817)
- Deferred charges and accrued income +€40,531
up €40,531 (+829%), from €4,888 to €45,418
- Financial fixed assets +€36,896
up €36,896 (+223%), from €16,567 to €53,463
- Trade debts -€189,724
down €189,724 (-97.0%), from €195,527 to €5,802
- Profit (loss) carried forward +€137,817
up €137,817 (+20.8%), from €663,793 to €801,610
- Tax, wage and social debts +€58,174
up €58,174 (+17.6%), from €330,342 to €388,516
of which Remuneration and social security: +€73,054
- Staff costs +€1.2m
up €1.2m (+82.2%), from €1.4m to €2.6m
- Turnover +€924,477
up €924,477 (+26.3%), from €3.5m to €4.4m
- Services and other goods -€293,347
down €293,347 (-15.8%), from €1.9m to €1.6m
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €1,210,067 | €1,216,334 | +€6,267 | +0.5% |
| Fixed assets | 21/28 | €162,918 | €191,010 | +€28,091 | +17.2% |
| Tangible fixed assets | 22/27 | €146,351 | €137,547 | -€8,804 | -6.0% |
| Plant, machinery and equipment | 23 | €2,412 | €8,970 | +€6,558 | +272% |
| Furniture and vehicles | 24 | €29,004 | €25,489 | -€3,516 | -12.1% |
| Other tangible fixed assets | 26 | €114,935 | €103,089 | -€11,846 | -10.3% |
| Financial fixed assets | 28 | €16,567 | €53,463 | +€36,896 | +223% |
| Other financial fixed assets | 284/8 | €16,567 | €53,463 | +€36,896 | +223% |
| Amounts receivable and cash guarantees | 285/8 | €16,567 | €53,463 | +€36,896 | +223% |
| Current assets | 29/58 | €1,047,148 | €1,025,324 | -€21,825 | -2.1% |
| Stocks and contracts in progress | 3 | €0 | €0 | = | |
| Amounts receivable within one year | 40/41 | €847,145 | €552,195 | -€294,950 | -34.8% |
| Trade receivables | 40 | €739,327 | €512,169 | -€227,158 | -30.7% |
| Other amounts receivable | 41 | €107,818 | €40,026 | -€67,792 | -62.9% |
| Cash at bank and in hand | 54/58 | €195,116 | €427,711 | +€232,595 | +119% |
| Deferred charges and accrued income | 490/1 | €4,888 | €45,418 | +€40,531 | +829% |
| Total equity and liabilities | 10/49 | €1,210,067 | €1,216,334 | +€6,267 | +0.5% |
| Equity | 10/15 | €684,198 | €822,015 | +€137,817 | +20.1% |
| Contributions | 10/11 | €18,550 | €18,550 | = | 0.0% |
| Reserves | 13 | €1,855 | €1,855 | = | 0.0% |
| Non-distributable reserves | 130/1 | €0 | - | = | |
| Reserves not available under the articles | 1311 | €0 | - | = | |
| Distributable reserves | 133 | €1,855 | €1,855 | = | 0.0% |
| Profit (loss) carried forward | 14 | €663,793 | €801,610 | +€137,817 | +20.8% |
| Amounts payable | 17/49 | €525,869 | €394,318 | -€131,550 | -25.0% |
| Amounts payable within one year | 42/48 | €525,869 | €394,318 | -€131,550 | -25.0% |
| Trade debts | 44 | €195,527 | €5,802 | -€189,724 | -97.0% |
| Suppliers | 440/4 | €195,527 | €5,802 | -€189,724 | -97.0% |
| Advances received on contracts in progress | 46 | €0 | - | = | |
| Taxes, remuneration and social security | 45 | €330,342 | €388,516 | +€58,174 | +17.6% |
| Taxes | 450/3 | €16,994 | €2,114 | -€14,880 | -87.6% |
| Remuneration and social security | 454/9 | €313,348 | €386,402 | +€73,054 | +23.3% |
| Operating income | 70/76A | €3,527,142 | €4,485,316 | +€958,174 | +27.2% |
| Turnover | 70 | €3,513,295 | €4,437,772 | +€924,477 | +26.3% |
| Other operating income | 74 | €13,847 | €47,544 | +€33,697 | +243% |
| Operating charges | 60/66A | €3,313,696 | €4,224,344 | +€910,648 | +27.5% |
| Services and other goods | 61 | €1,854,626 | €1,561,280 | -€293,347 | -15.8% |
| Remuneration, social security and pensions | 62 | €1,449,258 | €2,640,075 | +€1.2m | +82.2% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €7,763 | €21,169 | +€13,405 | +173% |
| Other operating charges | 640/8 | €2,048 | €1,820 | -€228 | -11.1% |
| Operating profit (loss) | 9901 | €213,446 | €260,972 | +€47,526 | +22.3% |
| Financial income | 75/76B | €37 | €55 | +€18 | +49.6% |
| Recurring financial income | 75 | €37 | €55 | +€18 | +49.6% |
| Other financial income | 752/9 | €37 | €55 | +€18 | +49.6% |
| Financial charges | 65/66B | €18,236 | €41,096 | +€22,860 | +125% |
| Recurring financial charges | 65 | €18,236 | €41,096 | +€22,860 | +125% |
| Debt charges | 650 | €17,968 | €41,032 | +€23,063 | +128% |
| Other financial charges | 652/9 | €267 | €64 | -€203 | -75.9% |
| Profit (loss) for the period before taxes | 9903 | €195,247 | €219,931 | +€24,684 | +12.6% |
| Income taxes | 67/77 | €61,994 | €82,114 | +€20,120 | +32.5% |
| Taxes | 670/3 | €61,994 | €82,114 | +€20,120 | +32.5% |
| Tax adjustments and reversals of tax provisions | 77 | €0 | - | = | |
| Profit (loss) for the period | 9904 | €133,253 | €137,817 | +€4,564 | +3.4% |
| Profit (loss) for the period to be appropriated | 9905 | €133,253 | €137,817 | +€4,564 | +3.4% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 18 October 2026 via checked.be.